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ABSTRACT: 
Antimicrobial resistant bacteria are a rapidly growing concern in human and veterinary 
medicine. The rising prevalence of extended spectrum beta-lactamase (ESBL), AmpC beta-
lactamase, carbapenemase (CRE), and flouroquinolone-resistant Enterobacteriaceae continually 
decreases the efficiency of vital antibiotics. Moreover, antibiotic resistant enteric bacteria can be 
transmitted between horses and people. Our objective was to evaluate the prevalence of antibiotic 
resistant bacteria on human contact surfaces in equine environments. Environmental surfaces in 20 
Ohio equine barns were sampled using two electro-static-cloths (Swiffer®), yielding a total of 200 
samples. Samples were screened for AmpC, ESBL, CRE, and fluoroquinolone phenotypic resistance 
using selective media. To select for cephalosporinase phenotypes, samples were incubated at 37°C 
in nutrient broth with 2 μg/mL cefotaxime. This broth was aseptically inoculated to MacConkey 
Agar with 8 μg/mL cefoxitin, 4 μg/mL cefepime, and 1 μg/mL meropenem to detect AmpC, ESBL, 
and CRE phenotypes, respectively. Additionally, samples were incubated in nutrient broth 
containing 16 μg/mL naladixic acid and then inoculated to MacConkey agar with 16 μg/mL 
naladixic acid and 2 μg/mL ciprofloxacin to detect fluoroquinolone resistance phenotypes. 
Genotypes were confirmed using standard PCR techniques. Of the 200 sampled surfaces, 39 
(19.5%), 17 (8.5%), 12 (6.0%), and 7 (3.5%) harbored cefoxitin, naladixic acid, cefepime, and 
ciprofloxacin resistant bacteria, respectively. Drains and wash stalls were most commonly 
contaminated at 18 (90.0%) of the 20 barns, followed by handles of mucking equipment at 12 
(60.0%) barns. These results suggest that equine environmental surfaces are contaminated with 
antibiotic resistant bacteria that can potentially be transmitted between human and horse 
populations. Furthermore, detecting these bacteria on common human contact surfaces suggests 
that the environment can serve as a reservoir for antibiotic resistance genes. Identifying 
interventions to lower the prevalence of antibiotic resistant bacteria in equine environments will 
protect both animal and public health.  
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INTRODUCTION: 
Background 
Bacteria resistant to multiple important antimicrobial drugs are one of the fastest growing 
concerns in both human and veterinary medicine, and the bacterial genes that regulate this 
resistance are continually evolving and diversifying. From an epidemiological standpoint, the 
detection and control of antibiotic resistance is crucial in maintaining the effectiveness of 
antibiotics against life-threatening pathogenic bacteria. The use of antibiotics provides selection 
pressure for the evolution and dissemination of antimicrobial resistant bacteria in both humans 
and animals, including horses. Settings that contain dense populations of animals, such as horse 
stables or barns, also facilitate the spread of resistant bacteria between animals due to their close 
proximity. The environment that these animals are housed in can retain the same resistant bacteria 
and aid in the dissemination process by serving as a reservoir for resistant bacteria or resistance 
genes.1 
Antimicrobial resistance can be classified based on the class of antibiotics to which the 
resistance is conferred and the type of resistance mechanism. Two classes of antibiotics, 
cephalosporin and fluoroquinolone, include powerful broad-spectrum antimicrobials critical to 
both human and veterinary medicine.2,3 Cephalosprorins, along with penicillins, are β-lactam 
antibiotics that target the transpeptidation reaction of peptidoglycan synthesis of the bacterial cell 
wall.4 To combat this drug, bacteria can produce β-lactamases, a group of enzymes that catalyze the 
β-lactam ring and cause the drugs to become ineffective.4 The first plasmid-encoded β-lactamase 
that expressed resistance to third generation cephalosporins, SHV-2, was identified in 1983.4 Due to 
the genes’ activity towards broad-spectrum cephalosproins, the corresponding family of resistance 
genes were termed Extended-spectrum β-lactamases.4 On the genetic level, some virulence-
associated mobile plasmids contain blaCMY, a cephalomycinase (CMY) gene that conveys resistance 
to first, second, and third generation cephalosporin antibiotics including cefoxitin and ceftriaxone.5 
4 
 
Bacterial resistance genes that confer heightened resistance to cefotaxime, another third generation 
cephalosporin, encoded by the plasmid-associated blaCTX-M β-lactamase gene are termed 
cefotaximases (CTX-M).4 CTX-producing bacteria also contain heightened resistance to fourth 
generation cephalosporins, such as cefepime, that are a more recently introduced generation of 
antimicrobial.J The bacterial family Enterobacteriaceae may commonly acquire both the blaCMY and 
the blaCTX-M gene on mobile plasmids.4,5 Additionally, Enrofloxacin (Baytril®) was the first 
fluoroquinolone introduced for use in veterinary medicine.6 The quinolone and fluoroquinolone 
classes of antibiotics prevent bacterial DNA replication by inactivating two type II topoisomerase 
enyzmes: DNA gyrase and topoisomerase IV.7 Resistance to these classes of antibiotics involves 
mutations to the gyrA and gyrB genes of DNA gyrase or the parC gene of topoisomerase IV.7 
Mutations to gyrB have been associated with low-level quinolone resistance whereas mutations in 
the gyrA gene are associated with high-level resistance.7 The second type II topoisomerase enzyme, 
topoisomerase IV, consists of two subunits: ParC and ParE.7 Mutations in both the parC gene, paired 
with gyrA mutations, are associated with high-level fluoroquinolone resistance.7  
The use of antimicrobial drugs in veterinary medicine, both in prophylactic or active 
treatment, can select for antimicrobial resistance in animal populations.B Isolates from cattle, 
poultry, swine, and retail meats were obtained from 5 states from 1998-2000 and produced 54 
Escherechia coli and 21 Salmonella enterica with the blaCMY gene.5 Additionally, blaCMY genes could 
undergo conjugation and transfer between bacterial species5, such as from commensal Escherichia 
coli to pathogenic Salmonella. Furthermore, direct antibiotic use was not correlated with the 
presence of the blaCMY gene, as some isolates containing the resistance gene were recovered from 
animals that had no previous history of cephamycin or extended-spectrum cephalosporin use.5 In 
2011, 1000 purchased packages of retail beef and pork from grocery stores located in two US states 
harbored 81 (8.1%) and 5 (0.5%) E. coli and Salmonella isolates encoding blaCMY genes, 
respectively.8 Another study in 2011 associated ceftiofur use, a third generation of cephalosporin, 
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in swine finishing barns with increased incidence of ceftriaxone resistance and the presence of 
blaCMY genes.9 Conversely, another study in 2011, blaCMY genes were recovered from 79% of the 
fecal samples (n=1,495) recovered from swine finishing barns in Ohio, Kansas, Illinois, Michigan, 
and Minnesota.10 Regarding blaCTX, 24 (1.6%) of these swine fecal samples harbored the gene, 
although only in Ohio, Michigan, and Illinois.10 In dairy cattle in Ohio, 747 fecal samples were 
obtained from 25 dairy farms and produced 711 (94.8%) isolates harboring the blaCMY gene from all 
25 herds and 70 (9.4%) isolates harboring the blaCTX gene from 5 herds.11 From a pathogen 
standpoint, 12 (0.6%) of 2,034 clinical Salmonella isolates in US livestock populations collected 
from 2010-2011 harbored the blaCTX gene on a mobile plasmids.12 ESBL-producing Salmonella were 
also identified in diagnostic submissions from horses located in Texas.12 All five equine-associated 
isolates likely originated from a common source because of their same state of origin and close 
genetic makeup (>97%).12  
Antibiotic resistant E. coli have been found in equine fecal samples from clinical settings in 
multiple studies.13,14,15 In one study, 450 of 650 fecal samples taken from hospitalized horses 
contained bacteria that were resistant to one or more antibiotics.16 In one clinical study, 60% of the 
bacterial isolates from critically ill foals were resistant to extended spectrum cephalosporins.17 
Further, ESBLs were present in the fecal samples of 55 of the 103 horses collected from in a referral 
equine hospital in England.15 Multi-drug resistant Salmonella were also responsible for the 
temporary closing of a large animal referral hospital, during which time the case fatality rate was 
31.5%.18 Furthermore, antibiotic resistance genes have been observed in the intestinal flora of 
healthy horses located in communal facilities in addition to sick horses in hospitals.19 From a single 
horseback riding center in the Czech Republic, the feces of 4 (9.0%) of the horses contained ESBL-
producing E. coli.20 
Because of increasing rates of antibiotic resistance, carbapenem antibiotics have become 
one of the last truly effective classes of antibiotics, but carbapenem-resistant Enterobacteriaceae 
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(CRE) are now becoming an emerging threat to modern medicine.21 In addition to their use in 
human medicine, carbapenems are sometimes used to treat equine bacterial infections that show 
resistance to most other antibiotics.22 Little to no information is known about the prevalence of 
CREs in horses or their environments, although carbapenemase-resistant Acinetobacter were 
isolated from the feces of two hospitalized horses in Belgium.23 There is also limited information on 
equine commensal bacteria that are resistant to fluoroquinolone antimicrobials, although one study 
found fluoroquinolone resistant bacteria in hospitalized horses in southeastern England.14 
Fluoroquinolones and cephalosporins are commonly used in equine medicine to treat bacterial 
meningitis because of the drugs’ ability to penetrate the blood brain barrier.24 Therefore, antibiotic 
resistance can cause severe complications in treating clinical cases of bacterial infection. Although 
extensive research has recorded the prevalence of antibiotic resistant bacteria in horses,13,14,15,16 
how the environment of equine centers facilitates the spread of antibiotic resistance is unknown.  
 
 
Justification 
Our objective was to estimate the prevalence of gram-negative coliform bacteria resistant to 
extended-spectrum cephalosporins, flouroquinolones, and carbapenems on surfaces in equine 
environments. Third and fourth generation cephalosporins are considered critically important 
antimicrobials according to the World Health Organization.25 The corresponding cephalosporinase-
producing genes are commonly present in fecal flora of animal populations, according to similar 
studies.1,14,15,16 Therefore, a greater prevalence of cephalosporin resistance was expected compared 
to carbapenem or flouroquinolone resistance on equine environmental surfaces. On the other hand, 
the percentage of cephalosporin resistance found on equine environmental surfaces was expected 
to be lower than that found in equine fecal samples because coliform bacteria proliferate more 
readily in the gut of animals compared to the exterior environment.  
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Horse owners, riders, and trainers typically follow standard hygienic procedures after 
handling, such as washing hands, tack, and equipment. This lowers the chance of a person 
introducing foreign bacteria into their body. However, the same safety precautions may not be 
observed after using equipment or interacting with the environment, such as opening doors or 
stalls. These surfaces could be contaminated with the same antibiotic resistant microbes present in 
the intestinal flora of horses and should be studied to determine the prevalence of antibiotic 
resistance in the environment. Such environments, therefore, could act as a reservoir for the 
transmission for various resistance genes.  
The potential zoonotic transmission of antibiotic resistant bacteria, or the ability to spread 
between humans and animals, contributes to the challenge in medicine of maintaining the 
effectiveness of antibiotics against microbes.25 For this reason, the environmental contamination 
and spread of antimicrobial resistant bacteria is a concern for animal and public health and should 
be evaluated. This is especially true because the antibiotics that this study utilizes are used in both 
human and animal medicine25, suggesting that the resistance genes would be effective in both 
populations. Identifying which animal environments are more prone to harboring antibiotic 
resistance will aid in creating more effective measures taken to stop the spread of antibiotic 
resistant bacteria amongst individual animals or across species.  
Bacteria can pass resistance genes to other species of bacteria via horizontal gene transfer 
on mobile plasmids.5 Commensal bacteria, even being non-pathogenic, can harbor resistance genes 
and thus act as a resistance reservoir for other bacteria including human pathogens, such as 
Salmonella.5 People can share intestinal flora with companion animals, such as horses, and thus 
acquire these resistant bacteria by a direct or indirect contact with horses or their environment. 
Knowing the extent of antibiotic resistance present in equine environments will allow prompt steps 
to be taken to prevent further dissemination of resistance genes among horses or across species to 
infect humans. For instance, a study in Greece estimated a 35% mortality rate of human patients 
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with bacterial infections attributed to resistant cases,26 which was higher than expected in patients 
with susceptible infections. Such evidence supports the fact that resistance genes are dangerous in 
human populations and bacterial transfer could possibly cause an antibiotic resistant infection. Pet 
owners may be more likely to pick up resistant bacteria shed by their companion animals due to 
regular interaction between the two species, thus increasing the risk of a resistant infection. 
 
METHODS: 
Sampling was conducted at privately owned horse facilities including boarding and riding 
stables. Samples were collected from a total of 20 equine facilities, with 10 environmental surfaces 
sampled from each facility, providing a total of 200 samples. This sample size was estimated based 
on an expected population size of 50-100 farms in the region of central Ohio and the ability to 
detect an estimated 10-30% antibiotic resistance prevalence rate with a 5-10% confidence 
interval.27 Samples were obtained from 10 various flat surfaces at each farm, including stalls, tack 
rooms, halters & lead ropes, feed rooms, storage rooms, pen gates, drains, cross ties &/or tie posts, 
mucking equipment, and water spigots. When sampling, only the areas most commonly touched by 
people were selected (ex: the handles of a mucking rake). The environment was sampled using 
electro-static-cloths (Swiffer®) following previously validated environmental sampling 
procedures28. Two samples were collected simultaneously from a single surface, one used to screen 
for AmpC, ESBL, and carbapenemase producing bacteria and the second used to screen for 
fluoroquinolone resistant bacteria. One sample from each surface was enriched in a nutrient broth 
containing 2 μg/mL cefotaxime. After incubation, this broth was inoculated onto MacConkey Agar 
with 8 μg/mL of cefoxitin, 4 μg/mL of cefepime, and 1 μg/mL of meropenem, in order to identify 
AmpC, ESBL and CRE phenotypes. The other sample from each surface was enriched in a nutrient 
broth containing 16 μg/mL of naladixic acid. After incubation, the nutrient broth was inoculated 
onto MacConkey Agar with 16 μg/mL of naladixic acid and 2 μg/mL ciprofloxacin. In order to 
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identify genotypes, isolates with the appropriate resistance phenotypes underwent genotyping 
using standard PCR techniques and gene sequencing.  
 
RESULTS: 
Of the 200 environmental samples collected from August to December, 2016, coliform 
isolates resistant phenotypes to all antibiotics were identified except for resistance to meropenem. 
(Table 1) The antibiotic that produced the most resistant isolates at 39 (19.5%) was cefoxitin. 
Naladixic acid produced the second-most resistant isolates at 17 (8.5%) isolates. Cefepime and 
ciprofloxacin followed at 12 (6.0%) and 7 (3.5%) isolates, respectively. More isolates were resistant 
to cefoxitin and naladixic acid than to their newer counterparts, cefepime and ciprofloxacin. 
Because cefoxitin has been in circulation longer than cefepime, the corresponding ESBL gene, 
blaCMY, has disseminated more among animal populations. The prevalence of resistance to cefoxitin 
compared to cefepime in this study supports this deduction. The same inference applies when 
comparing a quinolone such as naladixic acid to a fluoroquinolone such as ciprofloxacin. Again, the 
corresponding number of resistant isolates identified in this study support the same hypothesis, 
although to less of a degree. 
With the data separated by the 10 sampled surfaces from each individual barn, trends in 
antibiotic resistance contamination were observed. (Table 2) Due to the limit of 10 surfaces 
sampled at each facility, a maximum of 10 isolates could have been cultured from each barn as 
resistant to a specific antibiotic. The 75 total resistant isolates collected were represented over 14 
(70.0%) of the 20 barns. Thus, 6 barns expressed no bacterial isolates resistant to any of the four 
tested antibiotics. Some barns, such as Barns 4 and 14, contained a relatively large proportion of 
resistant isolates. When divided by environmental sample, the more commonly contaminated 
surfaces were identified. (Table 3) Based on the sampling procedure, the maximum number of 
isolates that could have been recovered from each surface was 20 due to 20 barns being included in 
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the sample. The most frequently contaminated surfaces included drains, mucking equipment, and 
stalls. Surfaces least contaminated were feed rooms, cross-ties and/or tie posts, and pen gates. 
Every environmental surface sample produced at least one resistant isolate over the 20 barns 
sampled. Upon genotyping the isolates expressing resistance to cefepime, a fourth generation 
cephalosporin, the specific gene within the Group 1 class of the blaCTX-M gene could be identified. All 
15 cefepime resistant isolates contained the blaCTX gene, with 2 (13.3%) of those isolates harboring 
blaCTX-M-15 and 13 (86.7%) harboring blaCTX-M-1.  
 
DISCUSSION: 
The use of cephalosporin and fluoroquinolone antibiotics in equine medicine occurs when 
treating patients with significant infections, especially respiratory tract infections, or when 
administering prophylactic treatment prior to surgery.25 Such antibiotic use selects for 
corresponding resistance genes in intestinal bacteria.13 In horses, ceftiofur – a third-generation 
cephalosporin – can be used to treat difficult bacterial infections, mainly of the respiratory tract.2,13  
Because both blaCMY and blaCTX-M ESBL genes confer resistance to third-generation cephalosporins, 
the use of ceftiofur in equine populations increases the propagation of both genes and their 
subsequent resistance profiles. Although an antibiotic such as ceftiofur is often administered in a 
hospital setting, previous studies have shown that horses are capable of shedding resistant bacteria 
upon returning to their barns after hospitalization.14,15 Our identification of both cefoxitin and 
cefepime resistance in non-medical equine facilities (Table 1) supports this analysis. These data 
suggest that surfaces regularly contaminated with fecal matter (drains, mucking equipment, and 
stalls) harbor antibiotic resistant bacteria that can be dispersed to other areas of the facility. 
However, 188 (94.0%) surface samples lacked resistance to cefepime and 161 (80.5%) of surface 
samples lacked resistance to cefoxitin. Thus, if bacterial isolates carrying blaCTX-M or blaCMY are 
present on more surfaces in equine barns or in a larger prevalence, they were either present in such 
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small amounts as to not be detected by the methods of our study, or they did not survive or 
proliferate efficiently outside of the gastrointestinal tract of the animals. The 15 recovered cefepime 
resistant bacteria underwent further genotypic characterization and identified a mix of blaCTX-M-1 
and blaCTX-M-15 β-lactamase gene with blaCTX-M-1 being more frequent. In the US, the blaCTX-M-1 gene has 
previously been isolated from livestock species whereas the blaCTX-M-15 gene has been identified 
from human and companion animal samples, as well as the environment.29 Due to the mix of blaCTX-
M-1 and blaCTX-M-15 genes, whether the isolates originated from livestock or human sources could not 
be conclusively determined, although blaCTX-M-1 appears more common.  
More surfaces remained uncontaminated by quinolone and fluoroquinolone resistant 
bacteria: 183 surfaces at 91.5% and 193 surfaces at 96.5% respectively (Table 1). The lower 
prevalence of quinolone and fluoroquinolone resistant bacteria compared to ESBL-producing 
bacteria is likely due to the limited use of fluoroquinolone antibiotics in equine medicine.6 The 
selection pressure by one antibiotic on resistance genes could also select for unrelated resistance 
genes if both genes are housed on the same conjugative plasmid. Therefore, the use of ceftiofur or 
another antibiotic used in equine medicine could translate to the proliferation of quinolone or 
fluoroquinolone resistance in this way. It should be noted that the methodology of this study 
heavily selects for any resistant bacteria present in a sample. For that reason, we are unable to 
determine the amount of resistant bacteria on individual surfaces; we are only able to state if there 
is resistance present. In addition, it is not known at what threshold abundance resistant bacteria 
reach a critical level that imposes a health risk to the horses or their handlers. 
The absence of resistant bacteria in 6 of the 20 barns (Table 2) would suggest that bacteria 
resistant to antibiotics are not of a significant clinical or epidemiological concern in general equine 
facilities in central Ohio. Of all of the resistant isolates identified, 23 (30.7%) were located in 2 of 
the 20 barns, likely due to clonal dissemination of a single resistant bacterium throughout the 
facility. More specifically, barns with a large number of isolates could contain bacterial clones 
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originating from a single host source that were then dispersed over various surfaces throughout the 
facility due to the dispersion of fecal matter. 
A single resistant bacterium in a barn may seem insignificant, but the resistance genes 
contained within it could potentially be transferred to pathogenic bacteria present in the same 
environment. Furthermore, if commensal bacteria also receive the resistance genes via conjugation, 
their proliferation in the hindgut further proliferates that gene in the microflora population. Thus, 
should an opportunistic pathogen arise, a dangerous antibiotic resistant infection may arise. Such 
was the case when a large veterinary teaching hospital was closed for an extended duration due to 
an outbreak of MDR Salmonella.18 The bacteria identified in this study, being primarily commensal, 
are shed from the gastrointestinal tract via fecal matter. A facility that houses horses, a species with 
a large daily output of fecal material, is difficult to maintain in terms of sanitation. As such, horses 
that harbor antibiotic resistant bacteria may spread the bacteria throughout the barn as their fecal 
matter is spread to equipment, surfaces, people, and/or other animals.  
Another epidemiological issue is the transfer of resistant bacteria from animal to animal or 
from animal to human. Areas such as the feed room, storage room, or tack room were contaminated 
with resistant microorganisms (Table 3), and because horses are not usually allowed in such areas, 
the bacteria was likely transferred there via humans as mechanical vectors. Many of the surfaces 
sampled (stalls, halters & lead ropes, pen gates, etc.) are a common surface shared by both a human 
and a horse. This presents an opportunity for fecal matter to be deposited by the horse and then 
transferred by the human. However, it is also possible that the resistant bacteria originated from 
the human population of a barn and then transferred to the equine population. Of the farms 
sampled, other livestock animal species such as chickens, cattle, and goats within close proximity to 
the horses were observed at 4 facilities whereas companion animal species, such as barn cats or 
dogs, were observed at all 20 farms. Trailers, cleaning equipment, and feeding locations are often 
shared between different species located on the same farm, and many of the animals share the 
13 
 
same pasture or facility areas. As such, the resistance genes could also have been picked up from 
equipment used for other species located at the same facility. Upon sequencing the cefepime 
resistant isolates to identify the blaCTX-M gene present in each bacterium, a mix of blaCTX-M-1 and 
blaCTX-M-15 carrying isolates were found (Table 4). Microorganisms with blaCTX-M-1 have been found in 
bacteria isolated from livestock species whereas those with blaCTX-M-15 have been found in bacteria 
isolated from humans. Although blaCTX-M-1 was identified in more of the isolates compared to blaCTX-
M-15 in this study, no conclusive inference could be made as to whether the cefepime resistant 
isolates originated from human, equine, or other animal sources. 
These results suggest that equine environmental surfaces are commonly contaminated with 
resistant bacteria that can potentially be transmitted between human and horse populations, 
although the exact transmission pattern is unknown. Identifying resistant bacteria on communal 
human contact surfaces suggests that the equine environment can serve as a reservoir for 
dangerous antibiotic resistance genes. Recognizing interventions to lower the prevalence of 
antibiotic resistant bacteria in equine environments will protect both animal and public health in 
the future. In order to determine the measurable severity of antibiotic resistance in equine 
populations, further studies will be necessary to quantify the amount of resistant bacteria present 
in the horses themselves or their environments. 
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Table 1: Total number and proportion of isolates resistant to specific antibiotics from 200 
environmental surfaces located on 20 privately owned equine barns in central Ohio. 
Antibiotic 
No. of Positive 
Isolates 
Proportion 
(n=200) 
Cefoxitin 39 19.5% 
Cefepime 12 6.0% 
Meropenem 0 0.0% 
Naladixic Acid 17 8.5% 
Ciprofloxacin 7 3.5% 
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Table 2: Number (proportion) of Gram-negative coliform bacteria resistant to cephalosporin, 
quinolone, and fluoroquinolone antibiotics recovered from environmental surfaces at 20 private 
equine barns in central Ohio. 
Barn Cefoxitin Cefepime Naladixic Acid Ciprofloxacin 
1 3 (0.3) 0 0 0 
2 4 (0.4) 0 0 0 
3 2 (0.2) 3 (0.3) 2 (0.2) 0 
4 4 (0.4) 0 5 (0.5) 1 (0.1) 
5 3 (0.3) 0 0 0 
6 0 0 0 0 
7 1 (0.1) 2 (0.2) 0 0 
8 4 (0.4) 0 1 (0.1) 1 (0.1) 
9 3 (0.3) 1 (0.1) 1 (0.1) 0 
10 3 (0.3) 2 (0.2) 1 (0.1) 0 
11 0 0 0 0 
12 1 (0.1) 2 (0.2) 0 0 
13 1 (0.1) 0 0 0 
14 2 (0.2) 2 (0.2) 5 (0.5) 4 (0.4) 
15 0 0 0 0 
16 3 (0.3) 0 2 (0.2) 1 (0.1) 
17 0 0 0 0 
18 0 0 0 0 
19 5 (0.5) 0 0 0 
20 0 0 0 0 
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Table 3: Number (proportion) of Gram-negative coliform bacteria resistant to cephalosporin, 
quinolone, and fluoroquinolone antibiotics recovered from 10 environmental surfaces at each of 20 
privately-owned equine barns in central Ohio.  
Surface Cefoxitin Cefepime Naladixic Acid Ciprofloxacin 
 1. Stall 5 (0.25) 1 (0.05) 4 (0.20) 1 (0.5) 
 2. Tack room 3 (0.15) 0 1 (0.05) 0 
 3. Halters & 
lead ropes 
5 (0.25) 1 (0.05) 3 (0.15) 1 (0.05) 
 4. Feed room 2 (0.10) 0 0 0 
 5. Storage 
room 
5 (0.25) 2 (0.10) 1 (0.05) 1 (0.05) 
 6. Pen gates 1 (0.05) 0 0 0 
 7. Drains 11 (0.55) 2 (0.10) 4 (0.20) 1 (0.05) 
 8. Cross-ties 
&/or tie post 
1 (0.05) 1 (0.05) 0 0 
 9. Mucking 
equipment 
5 (0.25) 3 (0.15) 2 (0.10)  2 (0.10) 
 10. Water  
Spigot 
1 (0.50) 2 (0.10) 2 (0.10) 1 (0.05) 
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Table 4: Sequencing results of 15 unique CTX Group 1 positive E. coli isolated from environmental 
surfaces at 6 privately owned equine barns located in central Ohio.   
Isolate No. Barn No. Surface Source CTX-M-Group 
1 3 Storage room A* CTX-M-1 
2 3 Storage room B* CTX-M-1 
3 3 Drains A* CTX-M-1 
4 3 Drains B* CTX-M-1 
5 3 Drains C* CTX-M-1 
6 3 Mucking equipment CTX-M-1 
7 7 Drains CTX-M-1 
8 7 Mucking equipment CTX-M-1 
9 9 Storage room CTX-M-1 
10 10 Mucking equipment CTX-M-1 
11 10 Water spigot CTX-M-1 
12 12 Stall CTX-M-1 
13 12 Cross ties CTX-M-1 
14 14 Halters & lead ropes CTX-M-15 
15 14 Water spigot CTX-M-15 
 
*Colonies with different morphologies on MacConkey agar that were isolated from the same surface 
sample. 
 
